Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The aim of this study is to compare the safety and efficacy of SBRT in LAPC with different biological effective dose (BED) (60-70Gy Vs.\>70Gy ) , to identify a dose range that could achieve better survival benefit and minimize the toxicity of radiotherapy.
Epistemonikos ID: 81ae3b22aff62999e7bafcee403a6ab74b861baa
First added on: May 07, 2024